Oncotarget
Media & Internet · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6666 E Quaker St Ste 1A, Orchard Park, N...Phone Number
(800) 922-0957Website
www.oncotarget.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Oncotarget
Oncotarget is a weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.Explore more
Oncotarget Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oncotarget your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Oncotarget
Click to see if Oncotarget had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Oncotarget has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Oncotarget recently announced quarterly report
Funding: Get notified immidiatlly once Oncotarget has new funding data
Oncotarget, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Oncotarget launches new products
Check out if Oncotarget is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Oncotarget as Masked Content
Find 3 more new buyers
Compare Similar Companies to Oncotarget
Compare insights from companies similar to Oncotarget, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oncotarget is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Oncotarget is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Oncotarget.
Oncotarget Tech Stack
A closer look at the technologies used by Oncotarget
Oncotarget News & Media
Oncotarget Publishes New Data by Lantern Pharma, an AI Company Developing Cancer Therapies, Further Supporting Clinical Advancement of LP-284, a Novel Synthetically Lethal Drug Candidate for Non-Hodgkin’s Lymphomas
DALLAS--(BUSINESS WIRE)---- $LTRN--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical stage drug programs, today announced the company has published new findings in Oncotarget demonstrating drug candidate LP-284’s in vitro and in vivo antitumor potency for multiple non-Hodgkin’s lymphomas (NHL), including mantle cell lymphomOncotarget: RAS reversion in colorectal cancer patients treated with bevacizumab
(Impact Journals LLC) This Oncotarget finding might have potential therapeutic implications, as anti-EGFR could be reconsidered in primarily RAS mutant patients reverted to a wild-type status after bevacizumab exposure.Oncotarget: CEA as a blood-based biomarker in anal cancer
(Impact Journals LLC) CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease.Oncotarget: Inhibitory effects of Tomivosertib in acute myeloid leukemia
(Impact Journals LLC) These Oncotarget findings demonstrate that Tomivosertib exhibits potent anti-leukemic properties on AML cells and support the development of clinical translational efforts involving the use of this drug.
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oncotarget
Sign Up For FreeTo access detailed company insights
Oncotarget is a weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.... Read More
